American International Holdings Corp.’s EPIQ MD Can Fill The Gap For 80 Million Underinsured Americans (OTCQB: AMIH)

American International Holdings Corp. (OTC: AMIH) is out to change the primary care landscape. And if they get their way, it will bring more than essential care to millions of people; it will deliver a revenue-generating catalyst to AMIH. 

Of course, that’s the plan at AMIH, which made its value proposition more compelling after announcing its Commercial Division launch for EPIQ MD, targeting new revenue-generating opportunities from small and medium-sized businesses (SMB’s). And it’s a plan in action, with AMIH exploiting its opportunities by targeting municipalities and companies in Alaska, Georgia, Illinois, and Texas.

Collectively, the initiative adds roughly 950,000 entities to AMIH’s target markets that need affordable, reliable, and attainable healthcare services for their workers. That adds to the more than 80 million people in the U.S. also needing primary care services.

Video Link: https://www.youtube.com/embed/MDSWGrMntso

EPIQ MD Combines Low Cost With High Efficiency

For AMIH, the expectation is for EPIQ MD to be a massive win. Best of all, that expectation can become a reality sooner than expected, especially with immense effort going into marketing the platform as a mainstream tool to effectuate primary care. And while AMIH expects to generate significant long-term revenue growth, reaching milestones along the way are catalysts for the stock as well. Hence, current levels may be entirely neglecting the impact its programs can have on near-term revenue generation.

Indeed, there are excellent reasons for AMIH and its investors to feel bullish about their prospects. Foremost, AMIH, through EPIQ MD, targets enormous untapped potential from the more than 950,000 business entities and the more than 80 million underinsured Americans needing affordable primary healthcare solutions. It’s no secret that millions of people have been priced out of the coverage market by surging medical costs. But, innovation can change that dynamic.

That’s AMIH’s intention. And they are aggressively extending the reach of its platform to meet that need. Earlier this month, they announced its commercial launch for EPIQ MD, which brings a second means to touch potential clients through small and mid-sized companies. And it’s a market they can help. 

In fact, given the opportunity, almost every business owner would provide comprehensive healthcare alternatives for their workers. The problem, though, is that most simply can’t afford even basic group insurance coverage. And that’s where EPIQ MD comes into play.  

Better yet, it’s more than coming into play. EPIQ MD is a solution that not only fills a gap but does so cost-effectively. Moreover, it may be the most comprehensive alternative treatment services package in the market. Even better, by tapping into the digital age, it could be the most convenient.

In The Right Market At The Right Time 

Better still, EPIQ MD is affordable and offers a lot of services for a little bit of money. Starting at $29.95 per month, EPIQ MD’s service options include Primary Care, Mental Health, Life Coaching, Prescription Discount Programs, and Ask-a-Medical-Expert. Better still, it’s not a one size fits all product. Employers can opt for customized branded solutions and even create specialized services that focus on particular areas like mental health or chronic disease management.

Most importantly, AMIH is offering an affordable solution to a compelling need. A 2018 report showed that 50% of individuals with employer-sponsored insurance say they were forced to decline or postpone getting healthcare and prescription drug coverage because of cost. AMIH believes it can change that dynamic by offering an effective and engaging service that can change the quality of life for its us

Best of all, employers can utilize AMIH’s platform as an alternative to more costly plans and, at the same time, alleviate much of the stress their employees have from not having health coverage. It’s a win-win proposition.

Massive Target Market In-Play

And from an investor’s perspective, here’s the best news- EPIQ MD is only the tip of the revenue-generating spear for AMIH. Beyond EPIQ MD, they are creating a portfolio of synergistic entities. Moreover, by developing scalable platforms, AMIH isn’t a pure medical services play. They also have a tremendous intrinsic value from capitalizing on the massive opportunities created by the digital revolution in healthcare.

Remember, digital services have gone from being revolutionary to being the norm. Everything from checking in, billing, patient visits, and test results is now provided digitally. Ang going forward, patients should expect their providers to further implement digital technology as a means to address office overhead and labor shortages. Thus, the medical services landscape is changing faster than most ever expected.

AMIH intends to monetize the movement.

Massive Target Market In-Play

From an investor’s perspective, here’s the best news- EPIQ MD is only the tip of the spear for the AMIH strategy of creating a portfolio of synergistic entities. Moreover, by developing scalable platforms, AMIH isn’t a pure medical services play. They also have a tremendous intrinsic value from capitalizing on the massive opportunities created by the digital revolution in healthcare.

Remember, digital services have gone from being revolutionary to being the norm. Everything from checking in, billing, patient visits, and test results is now provided digitally. And going forward, patients should expect their providers to further implement digital technology as a means to address office overhead and labor shortages. Thus, the medical services landscape is changing faster than most ever expected.

AMIH intends to monetize the movement.

Platforms Targeting A $4.2 Trillion Market 

And it’s a tremendous opportunity. As a whole, the revenue-generating potential is a $4.2 trillion industry opportunity. And its shift to a digitally-focused asset strategy should help them earn a piece of that potential. 

Part of that will come through ZipDoctor, its capital-efficient digitally-based platform that connects people and small businesses with healthcare practitioners. And it taps into telemedicine, which by the end of 2021 is expected to become a more than $194 billion industry. And ZipDoctor not only wants its share, they expect to earn it through EPIQ MD, which, as noted, represents the next generation in telehealth and wellness. Compared to already marketed products, it has differences and advantages.

Foremost, unlike mainstream companies like Teladoc that contract directly with health insurers, EPIQ MD targets a much broader market segment, namely the more than 80 million U.S. residents who are either under-insured or have no insurance at all. And AMIH thinks it can break into that market, with its own research showing that many of its target consumers, including small businesses, actually want to offer provider services and are willing to pay more for a comprehensive suite of wellness services. But, more isn’t the case with AMIH’s plan.

As noted, monthly subscription rates start as low as $29.95, and with that comes access to primary care physicians, mental health professionals, nutritional counseling, and deeply discounted rates to select third-party providers of prescriptions, in-person diagnostic, and lab services. Compared to an insurance premium, and it’s almost pennies on the dollar. The difference when using EPIQ MD is that those pennies per day provide an impressive amount of coverage.

Still, while that’s the primary value driver today, there’s more to like in the AMIH pipeline.

LifeGuru Is Also A Treatment-Changing Platform

LifeGuru is another compelling asset. It’s a life coaching platform that connects people with specialized life coaches with expertise mentoring people through life’s challenges. And not only in regards to stress. LifeGuru services expect to touch people to counsel romance, finance, career, health, and family issues. It’s a platform developing out of the challenges presented by COVID-19, which of course, wreaked havoc on the personal lives of more than 320 million Americans. And it still is.

Reports suggest that tens of millions of people continue to be impacted by COVID-19. And like it’s doing with ZipDoctor and EPIQ MD, AMIH seized upon its opportunity to develop a platform to help coaches access new clients nationwide and match people across the country with their optimal life coach. Better still, like its other platforms, LifeGuru targets a multi-billion-dollar sector opportunity. Also, it’s both accessible and affordable and provides a recurring revenue stream to AMIH through a subscription model. 

Singular or combined, AMIH assets offer a compelling value proposition. And while the markets are being whipsawed by headlines, it doesn’t alter the fundamentals in place at American International Holdings. Thus, if broader market weakness pulls AMIH stock lower, it intensifies the opportunity. 

Revenue Drivers At Work

The bottom line- AMIH is giving investors substantially more to consider than companies its size. Hence, looking at its assets instead of its share price provides a better look at what this company represents. The $0.07 price tag is not nearly enough to value its portfolio.

Moreover, as a multi-dimensional business that can develop several revenue streams, they deserve a multiple as well. That should come after its next update. And if traction is strong, with supporting revenues, expect shares to respond with bullish conviction.

One thing is for sure, AMIH is on a mission to turn digital into cash. And by having the assets, technology, ambition, and motivation to take their innovative platforms to the next level, they may very well succeed. Moreover, a positive update about EPIQ MD in the coming weeks could be the spark that lights the fuse to exponentially higher prices. Trading ahead of that news may be a wise consideration.

 

Disclaimers: Shore Thing Media, LLC. (STM, LLC.) is responsible for the production and distribution of this content. STM, Llc. is not operated by a licensed broker, a dealer, or a registered investment adviser. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The information made available by STM, Llc. is not intended to be, nor does it constitute, investment advice or recommendations. The contributors may buy and sell securities before and after any particular article, report and publication. In no event shall STM, Llc. be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or made available by STM, Llc., including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information in this video, article, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. STM, Llc. strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. For some content, STM, Llc., its authors, contributors, or its agents, may be compensated for preparing research, video graphics, and editorial content. STM, LLC has been compensated up to twenty-thousand dollars cash via wire transfer by a third party to produce and syndicate content for American International Holdings Group, Inc. for a period of one month. As part of that content, readers, subscribers, and website viewers, are expected to read the full disclaimers and financial disclosures statement that can be found on our website by visiting primetimeprofiles.com/disclaimer.

The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results.Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled.

Media Contact
Company Name: STM, LLC.
Contact Person: Michael Thomas
Email: Send Email
Phone: 973-820-3748
Country: United States
Website: https://amihcorp.com/